Plasma sialyltransferase activity in healthy subjects and atherosclerotic patients

Biochemistry (Mosc). 1999 Nov;64(11):1315-9.

Abstract

Plasma sialyltransferase activity measured by incorporation of cytidine 5;-phospho[14C]acetylneuraminic acid (CMP-NeuAc) into asialofetuin was twofold higher in patients with documented atherosclerosis than in healthy donors. Kinetic studies showed that the enzyme affinity for CMP-NeuAc is the same in donors and patients. Low activity of plasma sialyltransferase in donors may be due to low blood content of this enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arteriosclerosis / blood
  • Arteriosclerosis / enzymology*
  • Case-Control Studies
  • Cytidine Monophosphate / metabolism
  • Humans
  • Sialyltransferases / blood*

Substances

  • Sialyltransferases
  • Cytidine Monophosphate